Phase I Trial of Envafolimab for Healthy Male Subjects
Clinical trial NCT05849311 · COMPLETED
Trial details
- NCT number
- NCT05849311
- Sponsor
- 3D Medicines (Sichuan) Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-29
- Primary completion
- 2023-11-15
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.